Iclaprim reduces the incidence and severity of Staphylococcus aureus-induced septic arthritis in a murine model

Staphylococcus aureus is the most common non-gonococcal aetiology of septic arthritis. The efficacy of iclaprim against S. aureus LS-1, a clinical strain identified from a patient with septic arthritis, was studied in MF1 mice to evaluate the activity of iclaprim, which is in clinical development, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, D. B., Noviello, S., Gemmell, C. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Microbiology Society 2019
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481738/
https://www.ncbi.nlm.nih.gov/pubmed/32974543
http://dx.doi.org/10.1099/acmi.0.000052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481738/
https://www.ncbi.nlm.nih.gov/pubmed/32974543
http://dx.doi.org/10.1099/acmi.0.000052

Ejemplares similares